Merck's osteoporosis drug performs in Phase II
This is a discussion on Merck's osteoporosis drug performs in Phase II within the Biotechnology News forum, part of the Industry News and Updates category; Merck's experimental osteoporosis drug odanacatib turned in positive results in a Phase II trial. The drug reduced measures of ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
05-28-2008, 04:34 PM
|
|||
|
|||
Merck's osteoporosis drug performs in Phase II
Merck's experimental osteoporosis drug odanacatib turned in positive results in a Phase II trial. The drug reduced measures of bone turnover (breakdown and rebuilding of bone) in women with breast Read more...
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Analyst predicts a long delay for Merck's Cordaptive | industry_news | Biotechnology News | 0 | 05-06-2008 04:57 PM |
| SPOTLIGHT: Cancer drug flunks Phase III | industry_news | Biotechnology News | 0 | 03-19-2008 09:08 AM |
| Wyeth, Progenics drug flunks Phase III trial | industry_news | Biotechnology News | 0 | 03-19-2008 09:08 AM |
| Phase III data sinks Keryx's diabetes drug | industry_news | Biotechnology News | 0 | 03-11-2008 02:26 PM |
© 2008 DrugManagementForum™ powered by |
 |